Our results reveal that the expression levels of stemness (SOX2, c-MYC, Nanog, and OCT4) and EMT (N-cadherin) markers are positively correlated with the cisplatin resistance development of bladder cancer cells. The gene discussed is CDH2; the disease is urinary bladder carcinoma.